MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 12-06-2025
Insulet Corporation DIO Ratio 2011-2025 | PODD
Annual DIO Ratio Insulet Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 241 | 145 | 122 | 99.2 | 67.8 | 83.1 | 29.1 | 32.9 | 25.6 | 45.6 | 50.5 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 241 | 25.6 | 85.6 |
Quarterly DIO Ratio Insulet Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 208 | 206 | - | - | 240 | 249 | - | - | - | - | - | - | - | - | 329 | - | 240 | 209 | 175 | - | 127 | 109 | 126 | - | 134 | 152 | 149 | - | 133 | 154 | 100 | - | 64 | 68.3 | 74.7 | - | 82.6 | 87.9 | 58.4 | - | 27.6 | 36.5 | 56.5 | - | 32.4 | 33 | 28.3 | - | 25.6 | 26 | 34.5 | - | 44.7 | 47.3 | 44.4 | - | 41.5 | 61.1 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 329 | 25.6 | 108 |
DIO Ratio of other stocks in the Medical devices industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
75.1 | - | - | $ 1.77 B |  USA |
 |
Abiomed
ABMD
|
193 | - | - | $ 17.2 B | USA |
 |
Acutus Medical
AFIB
|
108 | - | -26.83 % | $ 2.62 M | USA |
 |
Lianluo Smart Limited
LLIT
|
50 | - | 24.59 % | $ 44.8 M |  China |
 |
Apyx Medical Corporation
APYX
|
213 | $ 3.86 | -3.26 % | $ 134 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
240 | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
237 | $ 307.92 | -1.93 % | $ 8.69 B | USA |
 |
Apollo Endosurgery
APEN
|
160 | - | - | $ 475 M | USA |
 |
BioSig Technologies
BSGM
|
7.1 K | - | 37.08 % | $ 85.7 M | USA |
 |
Bruker Corporation
BRKR
|
216 | $ 45.13 | -2.67 % | $ 6.72 K | USA |
 |
Allied Healthcare Products
AHPI
|
133 | - | 3.58 % | $ 2.21 M | USA |
 |
Abbott Laboratories
ABT
|
125 | $ 125.1 | 1.48 % | $ 218 B | USA |
 |
Boston Scientific Corporation
BSX
|
184 | $ 92.34 | 0.64 % | $ 136 B | USA |
 |
Conformis
CFMS
|
160 | - | - | $ 16.4 M | USA |
 |
CryoLife, Inc.
CRY
|
312 | - | -4.14 % | $ 702 M | USA |
 |
EDAP TMS S.A.
EDAP
|
163 | $ 2.56 | 8.94 % | $ 95.5 M |  France |
 |
Cardiovascular Systems
CSII
|
192 | - | 0.15 % | $ 844 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
247 | - | 1.15 % | $ 34.5 M | USA |
 |
Cutera
CUTR
|
135 | - | -10.19 % | $ 1.99 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
725 | $ 17.7 | -3.46 % | $ 408 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
212 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
272 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
10.1 | - | - | $ 111 M |  Canada |
 |
Eargo
EAR
|
85.3 | - | - | $ 10.2 M | USA |
 |
Dynatronics Corporation
DYNT
|
91.1 | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
145 | - | - | $ 955 M | USA |
 |
Xtant Medical Holdings
XTNT
|
281 | $ 0.73 | 4.33 % | $ 97.6 M | USA |
 |
InMode Ltd.
INMD
|
246 | $ 14.56 | 0.76 % | $ 1.15 B | Israel |
 |
Cognyte Software Ltd.
CGNT
|
76.7 | $ 9.88 | 0.05 % | $ 709 M | Israel |
 |
Second Sight Medical Products
EYES
|
175 | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
83.8 | $ 165.15 | 0.78 % | $ 12.4 B | USA |
 |
Accuray Incorporated
ARAY
|
164 | $ 1.07 | -3.18 % | $ 110 M | USA |
 |
Avinger
AVGR
|
332 | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
220 | $ 12.81 | -1.23 % | $ 346 M | USA |
 |
FONAR Corporation
FONR
|
13.9 | $ 14.86 | -0.03 % | $ 97.4 M | USA |
 |
AxoGen
AXGN
|
226 | $ 30.33 | 1.15 % | $ 1.34 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
290 | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
143 | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
211 | $ 40.78 | 2.33 % | $ 1.26 B | USA |
 |
Globus Medical
GMED
|
266 | $ 86.83 | -2.31 % | $ 11.8 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
205 | $ 13.41 | -4.56 % | $ 1.03 B | USA |
 |
Aziyo Biologics
AZYO
|
108 | - | 1.37 % | $ 20.5 M | USA |
 |
Alphatec Holdings
ATEC
|
304 | $ 20.04 | 0.65 % | $ 2.86 B | USA |
 |
Establishment Labs Holdings
ESTA
|
511 | $ 72.58 | -0.19 % | $ 2.04 B |  Costa-rica |
 |
IRIDEX Corporation
IRIX
|
125 | $ 0.92 | -4.72 % | $ 14.8 M | USA |
 |
Electromed
ELMD
|
91.2 | $ 29.74 | 0.64 % | $ 251 M | USA |
 |
IRadimed Corporation
IRMD
|
251 | $ 96.35 | -1.06 % | $ 1.22 B | USA |